Clinical trial

Effects of Continuous Positive Airway Pressure and Valsartan Treatments on…

NCT00409487 · University Hospital, Grenoble, Other · Completed

Key facts

NCT number NCT00409487
Title Effects of Continuous Positive Airway Pressure and Valsartan Treatments on Arterial Blood Pressure in OSAS Patients
Official title Comparative Study of Effect of Valsartan 160mg Treatment Versus Continuous Positive Airway Pressure on Arterial Blood Pressure in Patients Who Have an Obstructive Sleep Apnea Syndrome and a Weak or Moderate Hypertension.
Acronym VALSAS
Lead sponsor University Hospital, Grenoble, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Hypertension, Obstructive Sleep Apnea
Intervention type Device, Drug
Interventions Continuous positive airway pressure (CPAP), Valsartant treatment
Enrollment 60
Start date Dec 1, 2006
Primary completion Dec 1, 2006
Completion May 1, 2009
First posted Dec 11, 2006
Last update posted Sep 8, 2010
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies